|
HS Code |
628701 |
| Chemical Name | Androst-5-En-3-ol-7,17-Dione Acetate |
| Molecular Formula | C21H28O4 |
| Molecular Weight | 344.45 g/mol |
| Cas Number | 633-35-2 |
| Appearance | White to off-white crystalline powder |
| Melting Point | 168-172°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Storage Conditions | Store in a cool, dry place, tightly closed |
| Purity | Typically ≥98% |
| Iupac Name | 3β-Hydroxyandrost-5-en-7,17-dione 17-acetate |
| Synonyms | 7-Keto DHEA acetate, 7-Oxo DHEA acetate |
As an accredited Androst-5-En-3-ol-7,17-Dione Acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, tightly sealed HDPE bottle containing 25 grams, labeled "Androst-5-En-3-ol-7,17-Dione Acetate", batch number, and safety precautions. |
| Shipping | **Shipping Description:** Androst-5-En-3-ol-7,17-Dione Acetate is shipped in tightly sealed containers, protected from light, moisture, and extreme temperatures. Transport complies with all regulatory guidelines for handling laboratory chemicals. Proper labeling and documentation are included to ensure safe handling and delivery. Consult the Safety Data Sheet (SDS) for detailed transport and storage requirements. |
| Storage | Store Androst-5-En-3-ol-7,17-Dione Acetate in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry, and well-ventilated area, preferably at 2–8°C (refrigerator). Ensure it is segregated from incompatible substances, especially strong oxidizing agents. Clearly label the storage container and restrict access to trained personnel only. |
Applications of Androst-5-En-3-ol-7,17-Dione Acetate in Industrial ManufacturingAndrost-5-En-3-ol-7,17-Dione Acetate serves specialized functions as a key intermediate in advanced chemical synthesis routes for the pharmaceutical, veterinary, and biochemical reagent sectors. Manufactured to stringent process controls, our material addresses critical needs within each value chain, with strict adherence to global quality standards. 1. Corticosteroid Intermediate SynthesisThis acetate ester is widely used as a pivotal intermediate in the multi-step synthesis of corticosteroids such as prednisolone and hydrocortisone. Its acetylated form offers increased stability during oxidation and functional group transformations. Operators rely on this material during the early-to-mid stages of steroid side-chain modification. Process conditions like solvent selection and temperature control impact its deployment, while precise stoichiometry enables consistent yield, making it indispensable in regulated bulk API manufacturing environments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Synthesis of Anabolic Steroid PrecursorsChemical processors employ this compound for constructing the core building blocks that precede anabolic steroid APIs, notably for therapeutic and research applications. It features in side-chain modification and aromatization control steps, enabling precise structural configuration demanded in controlled anabolic production. The selection of acetate-protected intermediates enhances reaction specificity and batch-to-batch consistency, which is crucial for downstream validation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Veterinary Hormone SynthesisThe acetate-protected dione serves livestock pharmaceutical manufacturers as a precursor for progestogen and androgen hormones intended for veterinary use. It enters synthetic sequences following enzymatic or chemical hydrolysis to tailor hormone activity. Consistent quality and impurity profiling remain critical, as downstream applications in veterinary injections and implants require strict residue controls per regulatory frameworks. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Biochemical Standard and Diagnostic ReagentsSpecialty reagent manufacturers utilize Androst-5-En-3-ol-7,17-Dione Acetate for preparing reference materials and enzyme assay substrates, mainly in laboratory-scale and IVD (in vitro diagnostics) kit production. Its certified purity and traceability from GMP manufacturing facilitate reliable calibration and method development needed in quantification of steroid metabolism intermediates and enzymatic pathway studies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Androst-5-En-3-ol-7,17-Dione Acetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of Androst-5-En-3-ol-7,17-Dione Acetate that leaves our facility reflects the years we have spent perfecting our steroid intermediate lines. The model offered at our plant typically follows strict purity parameters—our technical workflow relies on thoroughly controlled conditions, beginning with solvent selection and extending through carefully timed reaction steps. Chemists here don’t just follow recipes; they track subtle differences each season can bring to raw material imports and tweak their approach, be it managing moisture content or adjusting for temperature drift that often slips past automation. Our team’s hands-on commitment matters because this molecule serves as a crucial building block in androstanoid research and various synthetic protocols.
Anyone working with androstene derivatives can spot how the specific placement of functional groups on the molecule influences both reactivity and downstream compatibility. With Androst-5-En-3-ol-7,17-Dione Acetate, the acetyl group at the 3-hydroxyl position brings a unique profile. We’ve tracked recurring patterns: research partners working with dehydroepiandrosterone or closely related precursors often prefer this acetate not only for its manageable melting point but because the acetylation gives improved handling in nonpolar media. Colleagues have commented on the difference during purification; chromatographic runs often yield tighter bands, with less background compared to non-acetylated dione analogs.
Measuring precise water content and acetate purity in each lot, we keep our NMR and IR spectra on record for long-term consistency, and include detailed impurity profiles in the lab datasheets—but only because it helps us troubleshoot or pinpoint a source of trouble before it becomes a batch-wide issue. Downstream operators have mentioned that this extra effort spares them costly surprises when scaling up a promising route.
Our teams frequently collaborate with researchers on custom specifications, but the bulk of our output needs to meet a high, predictable baseline for consistency. There’s an ongoing demand from contract labs and in-house R&D groups for a material that responds reliably to reductive or oxidative protocols. For instance, many routes moving toward novel androgens or advanced corticosteroid frameworks require this precise scaffold. We’ve taken notes from users who flagged subtle color changes in early batches—now, we finish each lot with additional filtration steps and hold samples for several weeks, watching for instability before signing off on a batch.
Over the years, experienced chemists have shared that minor impurities in raw intermediates often complicate scale-up or even derail entire projects. Real-world stories like these convinced us to refine our crystallization process, even if it slowed things down. The payoff is clearer—repeat customers notice when a synthetic step suddenly works cleaner or when downstream yields improve. Our technical staff relies not only on GC and HPLC readings, but regular collaboration with those carrying out pilot-plant syntheses, making sure our material performs across the full range of organic solvents, scalable reaction volumes, and purification techniques.
We’ve been repeatedly asked to explain the key practical differences between our Androst-5-En-3-ol-7,17-Dione Acetate and more common androst-4-ene derivatives. The conversation usually comes around to the stability of the 5-en scaffold, which resists over-oxidation better in particular hydrogenations. Teams working with heavily functionalized scaffolds mention that the acetate protection withstands conditions that would compromise unprotected hydroxyl groups. As a result, fewer side products build up during multistep routes—a benefit any pilot plant manager can appreciate.
Compared to the corresponding free alcohol or non-acetylated dione intermediates, our acetate sees less aerial oxidation and stays free-flowing longer during storage. Scientists working in hot, humid labs confirm that even minor acetylation improves shelf-life. We learned through one season of losses that packaging and desiccant choices deeply affect product stability, especially on the export leg of a shipment. Our warehouse now runs on stricter humidity control, using moisture meters rather than relying on visual checks. In the long span of day-to-day manufacturing, these incremental upgrades help maintain a better-performing intermediate on the bench.
Customers rarely want just the molecular basics; feedback always hones in on what works and where problems still remain. Laboratories using Androst-5-En-3-ol-7,17-Dione Acetate in synthesis routes for experimental SARMs, for instance, report improved yields when integrating our acetate compared with older stocks. This is not down to the molecule itself, but because close control of side-reactions at every batch stage left fewer reactive sites for competing pathways. We’ve assisted more than one client with side-by-side comparison reactions and kept their findings in the loop to tighten our own targets for purity and residual solvent control.
Pharmaceutical development teams target this intermediate for its versatility. Since its structure can serve both as a precursor to advanced corticosteroids and androgenic compounds, we often field requests for documentation on previous runs through specific transformations: solvent-free oxidations, regioselective acylations, or microwave-assisted protocols. Each context exposes hidden snags. Chemists chasing greener chemistry have even shared solventless trials with us; our material survived where less robust analogs could not. We document and share every unique use case internally, feeding best-practices straight into our next batch.
Handling in the plant informed our decision to adopt triple-vacuum drying—the step most batch records identify as critical for reducing hydrolytic degradation. Dry powders remain free-flowing, helping operators avoid caking during large-volume transfers. Many a workshop discussion circled back to the time saved and the waste avoided, convincing us to standardize this approach. Through direct experience, we learned that skipping these “small” steps leads to issues magnified on industrial scale.
Sourcing reliable intermediates can be a challenge, especially in a supply chain vulnerable to regulatory and logistical disruptions. Early on, a few years back, we ran up against inconsistent fermentation grades and solvent overlays that made actual synthesis work unnecessarily difficult. That experience sharpened our criteria for vendor qualification—today’s inputs come with full CoA, and the receiving lab double-checks mass balance before we move forward. Input solvents and acids undergo additional storage and testing long before reaction start. Any supplier who offers shortcuts is politely turned away.
Our sales and support teams hear about shipping conditions almost as often as synthesis troubleshooting. During one especially humid monsoon, several distant labs reported caking after transit—even though specs looked fine before shipping. We put our heads together with logistics, added heavier-duty linings, and started using two sets of silica pouches on all outbound containers. Feedback since then has shown consistently improved delivery condition and longer stability reports from partners in tropical climates. Those conversations proved vital for maintaining trust, and we pass the learnings straight back to our own packaging SOPs.
Development laboratories and scale-up plants rarely follow the same script—every team applies their own tweaks. We maintain open lines with users, collecting reaction notes and sometimes even visiting labs to see our product at work. These site visits routinely uncover optimization opportunities; for example, small changes in drying time or filter choice have cut rejection rates at several downstream manufacturers. On one memorable occasion, a downstream chemist flagged a trace impurity visible only in LC/MS at high levels; our quality team retraced every step of the batch and eventually pinpointed a source material change in a supplier’s fermentation lot. Fixing the source benefited not just that partner, but the entire production chain.
Shortened lead times make a major impact. Through workflow changes—optimized shift schedules, dedicated reaction vessels, customized filtration modules—we have reduced downtime between orders. Project managers in charge of sequential syntheses point out that every lost day scales into real costs when working under a clinical study timeline. Keeping their endorsement relies more on meeting precise timelines without failing quality than on making bold promises, so our workflow improvement team tracks every handoff across departments.
Sustainable chemistry matters here—and not because it is trending, but because every end-of-pipe issue comes back to the manufacturing plant. Chemistry labs located near agricultural zones owe their neighbors due diligence regarding effluent control. Our plant engineers reengineered drainage and added secondary recovery on volatile fraction scrubbers after one flagged incident during permit renewal. Operators learned that the best time to rethink a process is before neighbors file complaints. Today, every production run considers solvent selection for recovery and reclamation, not just purity outcomes.
Operators and technical staff attend regular hazard communication training as part of ordinary workflow. Androst-5-En-3-ol-7,17-Dione Acetate, like other fine chemicals, needs mindful handling through every stage, from weighing to transferring between reactors. Older hands know how even modest spills affect air quality or slip into scrap waste; having dedicated containment trays and backup scrubbers in work areas have reduced minor incident rates across all shifts. One of our most seasoned operators always double-checks PPE stocks before every campaign, and the habit quietly spread across teams.
Our experience manufacturing Androst-5-En-3-ol-7,17-Dione Acetate circles back to a simple insight—no batch succeeds in isolation. Customers, whether developing a new synthesis or scaling an API for clinical work, bring their own expertise and challenges. Many have encountered bottlenecks that standard documentation overlooks; sharing solutions in real time—operator notes, instrument screenshots, or even a photo of a characteristic precipitate—moves work forward faster than hours of email chains ever could. The partnerships forged around process troubleshooting have influenced not only outcomes on either side, but informed new best-practices here in our plant.
Chemists who trust us with their next project benefit from years of iterative refinement, not just clean product. They see a history of adaptation—be it an improved drying step, a new analytical check, or smarter packaging. When they bring feedback, challenges, or unconventional processing demands, those become catalysts for ongoing improvement in all our made-to-order intermediates, with Androst-5-En-3-ol-7,17-Dione Acetate as a touchstone for what thorough, experience-driven chemical manufacturing can look like.
We produce this compound not as an abstract commodity, but as an evolving solution grounded in open communication and the practical lessons learned in the field. Partner labs, scaling units, and R&D teams have shaped our product as much as any internal spec or reaction protocol ever has. Through continual investment in people, processes, and environmental responsibility, we ensure that each new batch not only meets its mark, but leaves a stronger foundation for those who innovate with it next.